Loblaw investing $75 million for minority stake in telemedicine agency Maple


TORONTO – Loblaw Corporations Ltd. has signed a deal to purchase a minority stake in telemedicine firm Maple Corp. for $75 million.

The corporate says the funding will probably be made via its Buyers Drug Mart Inc. subsidiary.

Maple helps individuals join with medical doctors and medical specialists utilizing a smartphone or pc and in addition supplies expertise for employers, insurers, hospitals and clinics.

Loblaw says Buyers Drug Mart has been working with Maple and its digital care is obtainable in additional than 160 Buyers Drug Mart areas in B.C.

The 2 corporations additionally labored collectively early within the pandemic to assist allow digital care visits.

Buyers Drug Mart has nearly 1,300 shops beneath its Buyers Drug Mart and Pharmaprix banners.